Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Fmoc-L-Valinol

    • Product Name Fmoc-L-Valinol
    • Alias (S)-2-((9H-fluoren-9-yl)methoxycarbonylamino)-3-methyl-1-propanol
    • Einecs 852-736-2
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    225285

    Product Name Fmoc-L-Valinol
    Cas Number 128223-58-1
    Molecular Formula C20H25NO2
    Molecular Weight 311.42
    Appearance White to off-white solid
    Melting Point 76-80 °C
    Purity ≥98%
    Solubility Soluble in DMSO, DMF, methanol
    Storage Temperature 2-8°C
    Smiles CC(C)[C@@H](CO)N(C=O)OCc1ccccc1
    Inchi InChI=1S/C20H25NO2/c1-15(2)18(14-22)21-19(22)23-13-16-10-6-4-8-12-16/h4,6,8,10,12,15,18,22H,13-14H2,1-2H3/t18-/m0/s1

    As an accredited Fmoc-L-Valinol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing White plastic bottle with a secure screw cap, labeled "Fmoc-L-Valinol, 5g" with hazard symbols, batch number, and supplier details.
    Shipping Fmoc-L-Valinol is shipped in tightly sealed containers, protected from light, moisture, and extreme temperatures. It is classified as a chemical reagent and must be packed according to local, national, and international regulations for safe transport. Ensure proper labeling, documentation, and handling to maintain product integrity during transit.
    Storage Fmoc-L-Valinol should be stored in a cool, dry, and well-ventilated area, away from heat and sources of ignition. Keep the container tightly closed to prevent moisture absorption and protect from light. Store at 2–8°C, and avoid prolonged exposure to air. Ensure the chemical is clearly labeled and segregated from incompatible substances, such as strong oxidizers or acids.
    Application of Fmoc-L-Valinol

    Applications of Fmoc-L-Valinol in Industrial Manufacturing

    Our production of Fmoc-L-Valinol supports advanced peptide synthesis and specialty chemical manufacturing, which require consistent quality, documented traceability, and application expertise. Here, we demonstrate the specific industrial processes and compliance frameworks for downstream applications in the pharmaceutical, biotechnology, and fine chemical sectors.

    1. Solid Phase Peptide Synthesis (SPPS) for Pharmaceutical APIs

    Fmoc-L-Valinol serves as a protected amino alcohol building block for custom peptide API synthesis, including complex cyclic peptides and peptidomimetics. Synthesizers use its defined chirality and protecting group compatibility to ensure precise chain extension and high sequence fidelity. Implementation in multi-kilogram batch manufacturing requires strict adherence to regulatory guidance and traceability for pharmaceutical ingredients.

    Industry compliance standards

    • ICH Q7 (Good Manufacturing Practice for Active Pharmaceutical Ingredients)
    • USP <797> / EP 2.9.47 (Peptide Standards for Pharmaceutical Raw Materials)
    • 21 CFR Part 210/211 (FDA cGMP for Finished Pharmaceuticals)
    • European Pharmacopoeia (Peptide API Monographs)

    Typical usage ratio

    • 0.6–1.2 molar equivalents per coupling cycle, calculated by resin loading and target peptide length; adjusted for coupling efficiency and chain completeness.

    Downstream process integration

    • Direct introduction during amino acid extension phase in SPPS cycles, after swelling and deprotection steps, prior to subsequent coupling or cyclization; monitored by HPLC and NMR to ensure correct attachment and purity.

    Final product types

    • Active pharmaceutical ingredient (API) peptides, specialized cyclic and linear peptides, GMP research peptides, and peptide intermediate fragments for later-stage modification or conjugation.

    2. Synthesis of Peptidomimetic Scaffold Intermediates

    Fmoc-L-Valinol enables the construction of non-natural peptidomimetic scaffolds, replacing conventional amino acids to improve target compound stability or bioavailability. Medicinal chemists employ this intermediate in combinatorial libraries and small-molecule lead optimization, where the hydroxyl function and chirality introduce key structural variations.

    Industry compliance standards

    • OECD Principles of Good Laboratory Practice (GLP, 21 CFR Part 58)
    • REACH Registration for specialty intermediates (where required for commercial quantities in the EU)
    • ISO 9001:2015 (Quality Management System for Laboratory Synthesis)
    • USP <1092> (Excipients for Use in Synthesis)

    Typical usage ratio

    • 10–25% molar equivalents relative to total scaffold units; varies depending on substitution patterns and target molecular architecture.

    Downstream process integration

    • Incorporation during scaffold elongation or ring-closure reactions, coupled via activated ester or carbodiimide chemistry (e.g., EDC/HOBt), followed by deprotection and subsequent derivatization.

    Final product types

    • Highly functionalized peptidomimetic intermediates, drug screening compounds, combinatorial library members, and contract-manufactured research compound batches.

    3. Development of Chiral Ligands for Asymmetric Synthesis

    Chiral alcohols such as Fmoc-L-Valinol are integral to the synthesis of enantiomerically pure ligands and auxiliaries, supporting advanced asymmetric catalytic processes in fine chemical and API manufacture. Synthetic chemists modify this intermediate via further functionalization to yield ligand frameworks with precise steric environments for transition metal catalysis.

    Industry compliance standards

    • ISO 9001:2015 (Quality Systems for Fine Chemical Manufacturing)
    • Responsible Care® Management System (Chemical Industry Global)
    • REACH Chemical Registration Requirements (for ligands/intermediates in the EU)
    • Specific application requirements from the downstream customer (custom specifications for ligand purity and traceability in catalyst manufacture)

    Typical usage ratio

    • 0.1–0.5 equivalents per ligand synthesis cycle, depending on catalyst design and metal center compatibility; adjusted by the desired ligand-to-metal stoichiometry.

    Downstream process integration

    • Employed during chiral backbone construction, following selective functionalization and condensation with additional heteroatom or aromatic groups to yield chelating ligands; followed by purification via preparative chromatography.

    Final product types

    • Chiral phosphine ligands, chiral oxazoline-based ligands, tailor-made ligands for organometallic asymmetric catalysts, and specialized chiral reagents for proprietary processes.

    4. Preparation of Custom Amino Alcohol Derivatives for Bioconjugation

    Fmoc-L-Valinol serves as the base molecule for synthesizing protected amino alcohol derivatives used in site-specific bioconjugation. These derivatives support the introduction of linker moieties or functional handles on biomolecules, enabling tailored conjugation strategies for diagnostics, biomaterials, and antibody-drug conjugates. Precise control over the protecting group and chirality is crucial for reproducibility and downstream functionalization.

    Industry compliance standards

    • ISO 13485:2016 (Quality Management in Medical Device and Diagnostic Manufacturing)
    • 21 CFR 820 (FDA Quality System Regulation for Medical Devices)
    • OECD GLP for Preclinical Bioconjugation Studies
    • USP <1047> (Analytical Validation for Biologic Conjugates and Devices)

    Typical usage ratio

    • Up to 15 wt.% within linker or pegylation formulations; optimization based on target molecule reactivity and conjugation efficiency with proteins or other biomacromolecules.

    Downstream process integration

    • Pre-functionalization stage for amino alcohol derivatives, followed by selective coupling to activated esters or click-chemistry partners, subsequent purification and integration into bioconjugation workflows.

    Final product types

    • Site-specifically labeled peptides, antibody-drug conjugates, diagnostic reagents, and novel biocompatible linker systems for pharmaceutical and research applications.
    Free Quote

    Competitive Fmoc-L-Valinol prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Fmoc-L-Valinol — Precision in Chiral Synthesis

    Introducing Fmoc-L-Valinol

    Years of hands-on chemical manufacturing teach real lessons about what matters at the bench and at scale. In our daily work, we see the difference a well-thought-out reagent can make. Fmoc-L-Valinol stands as a key building block for peptide chemists who demand reliable protection of amino functionalities along with manageable deprotection properties. The Fmoc group in this molecule supports a clean, base-labile removal step—an essential feature when constructing complex molecular targets.

    This compound’s strength lies in its combination: a protected amine from Fmoc and a free alcohol, offering practical options in sequence extensions and side-chain modifications. Chemists in both academic and pharmaceutical labs face pressure to deliver optically-pure, analytically-sound intermediates, especially in multi-step syntheses. Synthetic strategies often rely on stereochemistry retention and mild reaction pathways, both areas where our Fmoc-L-Valinol delivers consistent results.

    We observe that platforms using Fmoc-L-Valinol for chiral ligand synthesis, peptidomimetic design, and even catalytic asymmetric transformations can proceed without battling unnecessary byproducts or impure intermediates. Technical teams evaluate every batch using HPLC and NMR—because knowing the material meets the real-world bar is part of our philosophy. Our experience underlines that generous specification on assay (typically above 98%) and strict control over water and residual solvents means fewer headaches during purification steps downstream.

    Model and Specifications

    From repeated laboratory-scale trials and industrial productions, physical handling always tells part of the story. Fmoc-L-Valinol is produced in white to off-white crystalline form, with good solubility in DMF, DCM, and moderate polar aprotic solvents. Its melting point and stability enable reliable storage at room temperature when sealed from atmospheric moisture. We ship and use lots that consistently uphold specification: high chemical purity, single major enantiomer, and low residual organic content. Neat product gives the tactile proof—granular, free-flowing, and easy to portion for immediate use.

    Our manufacturing lines avoid overcrowding the process with extraneous reagents. Minimizing contamination risk begins during synthesis, especially after the Fmoc protection step, which can introduce side-products if handled poorly. We circle back each run with full analytical data, then compare against batch retention samples. Colleagues accustomed to troubleshooting substandard lots appreciate the difference between a genuine, in-house manufactured product and something of vague provenance.

    What Sets Fmoc-L-Valinol Apart

    Working directly in syntheses where Fmoc-L-Valinol serves as a critical intermediate, the hands-on crew recognizes how its stereo-defined architecture performs in asymmetric transformations. Competing products suffer from lackluster purity or inconsistent chiral content. Sometimes, high-throughput setups stall at the protection step due to unwanted polymerization or insoluble artifacts. We designed manufacturing protocols around robust chiral sources, maintaining optical rotation within narrow brackets and tracking every lot for trace impurities.

    Years in the chemical plant expose the consequences of inconsistent protection group chemistry. Our synthesis route avoids using excessive reagents, which often generate colored impurities—trouble in purification. Knowing these obstacles, our chemists developed workups that keep color and odor to a minimum. Fmoc removal using piperidine works smoothly in our experience, with the product dissolving quickly and releasing the alcohol without heavy byproduct formation. Crude yields speak for themselves—no endless cycles of silica column just to reach a “clean enough” state.

    Reliability for Peptide and Chiral Ligand Research

    Long-standing relationships with academic and pharmaceutical method developers inform our approach. Researchers who deal with inconsistent performance in Fmoc derivatives reach out to us for something more dependable. Our Fmoc-L-Valinol finds its role in linker strategies that require orthogonal protection/deprotection regimes, essential in solid-phase peptide synthesis. Its utility for N-terminal modifications, or as an auxiliary in establishing C2 symmetry, underpins many projects now moving into more advanced clinical stages.

    We actively collaborate with downstream users to optimize parameters such as coupling efficiency, solubilization behavior, and compatibility in mixed organic/aqueous media. Every production run reflects input from feedback cycles. For example, some customers sought tighter microanalytical controls; response brought adjustments in our analytical QC suite, ensuring even tighter impurity cutoffs. It might seem like a small detail, but in combinatorial and high-throughput systems, shaving time off intermediate purifications translates directly to improved throughput.

    Process Considerations and Batch Control

    Engineers and synthetic chemists under our roof understand that batch consistency both saves money and preserves research timelines. Over years of scaling Fmoc-L-Valinol, we identified where process drift and contamination tend to emerge—catalyst carryover, incomplete deprotection of prior runs, and micro-scale water ingress. Early on, we prioritized closed-system evaporation and nitrogen-purged transfers, reducing oxidative discoloration and water adduct formation.

    Documentation and sample archiving remain priorities. Batches come with complete spectral and chromatographic profiles kept on file. Requests for COA or supplementary trace data are answered by people who built the batch rather than generic sales staff. Our team would rather delay a shipment than send out a lot that leaves the end-user cleaning up after our process. Many times, steady repeat business came after new customers compared direct performance to anonymous-catalog material—fewer unexplained side-products, more reliable coupling statistics, and cleaner mass spectra.

    Comparing Alternatives

    The world of protected amino alcohols spans various protecting groups and chiral backbones. At this scale, mass-market catalog suppliers often favor throughput over craft, leaving trial labs to cope with inconsistent melting points or unexplained TLC spots. We’ve countered that by standing behind our single-sourced, traceable Fmoc-L-Valinol—no blended lots, no “grey” intermediates. Direct users often remark how switching from benzyl or tert-butyl protected analogues cost extra steps or risked racemization under basic or acidic conditions. Our Fmoc-protected design enables swift cycling between protected and deprotected states, key for programmable workflows.

    Whereas Boc or Alloc protection pairs with certain alkoxy amines, their removal frequently leans on more hazardous or handling-intensive reagents. In our work, Fmoc-L-Valinol offers greater compatibility with base-sensitive partners and more predictable yields after piperidine treatment. Problems from acid-catalyzed cleavage—resin or backbone degradation—simply don’t emerge with our product. For researchers, the chemistry’s repeatability trumps uncreative cost-cutting substitutes.

    Some alternatives provide similar protection, but inconsistent chiral purity or unpredictable reactivity. Cheaply-managed lots can sneak in mixed stereoisomers or excessive residual solvents, derailing critical stereocontrolled syntheses. Our Fmoc-L-Valinol is tested every time for enantioselectivity and trace contaminants—parameters the seasoned synthetic chemist recognizes matter more than abstract theoretical “purity.” We learned this from years working with researchers who must explain every deviation at a regulatory or internal review.

    Operational Details from Our Own Manufacturing Experience

    Our chemical plant layout grants direct control over the protection cycle. Starting with carefully vetted L-Valinol, our operators perform Fmoc chloride addition under controlled cooling, tracking color and solution viscosity at each stage. Titration and spot-test TLCs, often neglected in remote branches of large operations, run side-by-side with mainline HPLC for final material. Through plenty of iterations, we confirmed that using too aggressive a base leads to local exotherms and color formation, problems we headed off by implementing slower, metered addition and better mixing geometry.

    Crystallization and drying step always draw attention to water removal. Late-stage washing with cold, dry solvents improves color and leaves a free-flowing powder suited for both benchwise scooping and automated vialing. Securing air-tight packaging closes the loop, as atmospheric moisture saps both stability and confidence. Our packs avoid cornstarch or other flow-aids; only main product leaves the final drum. Technicians taking pride in handling real chemical know that residue left behind today creates doubts on the next job—so they keep their workspace nearly spotless, and the product reflects that discipline.

    Real-World Results from Downstream Users

    In conversations with our customers, the theme circles back to practical gains from clean, reliable Fmoc-L-Valinol. An organic synthesis group running peptide analog experiments noted their coupling times shortened noticeably; they attributed this to cleaner dissolving profiles and reduced background fluorescence after deprotection. Analytical teams, previously frustrated by wandering chromatographic baselines, reported nearly complete absence of ghost peaks with our batches.

    Formulation teams using Fmoc-L-Valinol en route to new chiral ligands in asymmetric catalysis found more reproducible effects in screening. In one effort, a process development scientist mentioned that yield optimizations transferred seamlessly from bench to pilot scale—no hidden off-odors, no variable melting ranges. These types of direct reports matter more than abstract promotional language.

    For resin-bound peptide work, especially in projects exploring sequence modifications or crosslinkers, in-house trial runs confirmed that coupling, washing, and cleavage cycles progress with low background interference. This cuts down on wasted wash cycles and improves stepwise yield, giving more freedom to plan the next sequence extension without patching over prior losses.

    Environmental and Safety Reflection from Years in Production

    Production of Fmoc-L-Valinol encourages our ongoing focus on minimizing hazardous waste and solvent recycling. We redesigned wash steps to recover and purify solvents, making both economic and ecological sense. Over time, inline monitoring systems flagged emission peaks tied mostly to poorly vented additions or batch over-concentration, so we revamped ventilation and reworked addition timings. These moves keep our own staff safe and government regulators uninterested in paying a visit. Every crew member completing a batch or packing order works from a file with the real, not hypothetical, hazards and protective advice for every step.

    Personal protective equipment, clever local exhaust, and process audits do more good for daily safety than any “top-down” mandate. Feedback from our operators—good and bad—cycles into the morning toolbox meetings, making sure everyone knows about the batches that went overboard and what worked instead. We think chemical manufacturing shows its best face through open discussion, routine re-evaluation, and the willingness to halt a run for safety review, no matter where production stands.

    How Continual Improvement Shapes Our Product

    Our manufacturing group gives space for researchers and production staff to propose changes based on real usage—small tweaks in drying times, alternative solvent systems, or new filtration media. Over time, this input has reduced running costs and waste by significant margins. Analytical chemists cross-check every change against retained batch samples and make sure the next batch keeps up the same color, melting point, and reactivity.

    We share lessons with collaborators and customers, aiming to spread tried-and-tested process tweaks to other labs facing similar hurdles. One year, supplier disruptions forced an overhaul of our baseline L-Valinol source. Rather than risk unknowns, we compressed the qualifying timeline and ran small-batch controls alongside the new source, confirming no differences in product character, reaction rates, or color outcome. New recruits learn how even subtle changes on paper become pronounced after scale-up—using data, not guesswork, to guide the transition.

    The Philosophy Behind Fmoc-L-Valinol Production

    Years of manufacturing taught us the difference between good material and simply marketable material. We view each batch as an extension of our own reputation: every bottle shipped carries careful effort, accurate specification, and clear accountability. We don’t see Fmoc-L-Valinol as a commodity, but as a reliable partner in R&D projects that must meet high analytical standards and withstand demanding scrutiny. Each laboratory’s job becomes easier with predictable, transparent batch information.

    We manufacture Fmoc-L-Valinol in direct response to research and industrial challenges presented to us by our partners. Problems—impure material, unreproducible chiral outcomes, unexpected degradation—drove us to refine our own methods, not just because it looks good on paper but because every chemist on our floor wants the tools to work properly the first time. Operators in our plant all value how responsibility for the product’s integrity rests with the folks who make and use it, with real stakes for getting it right.

    Commitment to Reliable Research Outcomes

    Fmoc-L-Valinol’s place on the bench speaks to more than an abstract chemical identity. Our manufacturing underscores a commitment to supplying material that stands up to day-in, day-out usage by skilled practitioners. We believe a strong supplier builds on transparency—clear, specific data and proactive support when conditions change. Problems surface, but we address them in open dialogue, so chemists facing hurdles with their syntheses find answers grounded in technical understanding or process improvement, not vague assurances.

    We never lose sight of the fact that most users evaluating a batch hold high standards and expect dependable results. From packing staff to technical managers, each step reflects shared responsibility—each bottle that leaves our floor demonstrates both the science of manufacturing and the pride of hands-on teams. Results, not just theory, prove the worth of what we produce.